PERSPECTIVE THERAPEUTICS, INC. Inventory
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Inventory of $1.01 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2023-11-14
- 2023-09-30: Inventory, Net $1.01M.
- 2023-06-30: Inventory, Net $1.09M.
- 2023-03-31: Inventory, Net $1.41M.
- 2022-12-31: Inventory, Net $1.41M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2023-09-30 | $1.01M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.09M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $1.41M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.41M 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $1.55M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.40M 10-KT · filed 2023-05-01 | |
| 2022-03-31 | $1.16M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.07M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $1.06M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $980.00K 10-KT · filed 2023-05-01 | |
| 2021-03-31 | $731.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $665.00K 10-Q · filed 2021-02-09 | |
| 2020-09-30 | $641.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $645.00K 10-K · filed 2021-09-27 | |
| 2020-03-31 | $580.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $545.00K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $501.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $530.00K 10-K · filed 2020-09-25 | |
| 2019-03-31 | $533.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $494.00K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $487.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $494.00K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $458.00K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $459.00K 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $453.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $323.00K 10-K · filed 2018-09-26 | |
| 2017-03-31 | $314.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $381.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $380.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $334.00K 10-K · filed 2017-09-28 | $334.39K 10-K · filed 2016-09-09 |
| 2016-03-31 | $457.29K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $476.75K 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $460.56K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $403.95K 10-K · filed 2016-09-09 | |
| 2015-03-31 | $464.56K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $411.42K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $407.48K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $359.74K 10-K · filed 2015-09-14 | |
| 2014-03-31 | $387.02K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $426.33K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $436.24K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $405.57K 10-K · filed 2014-09-29 | |
| 2013-03-31 | $356.98K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $402.91K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $410.46K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $444.35K 10-K · filed 2013-09-30 | |
| 2012-03-31 | $441.19K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $806.18K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $761.91K 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | $749.85K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |